Fischer Medical Ventures Limited (NSE:FISCHER)
India · Delayed Price · Currency is INR 25.20
+0.26 (1.04%)
Nov 11, 2026, 1:30 PM IST
Fischer Medical Ventures Revenue
Fischer Medical Ventures had revenue of 819.20M INR in the quarter ending June 30, 2026, with 249.42% growth. This brings the company's total for the last twelve months to 3.67B, up 195.95% year-over-year. In the fiscal year ending March 31, 2026, Fischer Medical Ventures had annual revenue of 3.09B with 178.75% growth.
Revenue (ttm)
3.67B
Revenue Growth
+195.95%
P/S Ratio
4.46
Revenue / Employee
229.41M
Employees
16
Market Cap
16.53B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 3.09B | 1.98B | 178.75% |
| Mar 31, 2025 | 1.11B | 897.17M | 427.61% |
| Mar 31, 2024 | 209.81M | 208.02M | 11,588.75% |
| Mar 31, 2023 | 1.80M | - | - |
| Mar 31, 2022 | - | - | - |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 616.31B |
| Divi's Laboratories | 121.91B |
| Lenskart Solutions | 103.83B |
| Laurus Labs | 78.23B |
| Krsnaa Diagnostics | 8.86B |
| Tarsons Products | 4.41B |
| Beta Drugs | 4.10B |
| Accent Microcell | 3.85B |
Fischer Medical Ventures News
- 1 year ago - Fischer Medical Ventures launches Chennai’s first high-resolution open MRI at Sunray Scans - Business Upturn